| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |